Deals of the day-Mergers and acquisitions
Medical device maker Solventum will acquire Acera Surgical for up to $850 million. Enterprise Products Partners and Exxon Mobil will expand the Bahia natural gas liquids pipeline. Abbott will buy Exact Sciences for up to $23 billion. Generali, BFF Bank, and BPCE advance in bidding for GamaLife. Palo Alto Networks will acquire Chronosphere for $3.35 billion.
Nov 20 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1430 GMT on Thursday:
Medical device maker Solventum <
SOLV.N
- said it would acquire privately held Acera Surgical for up to $850 million to expand its wound-care portfolio.
Enterprise Products Partners <
EPD.N
- said that Exxon Mobil <
XOM.N
- will buy a 40% stake in its Bahia natural gas liquids pipeline and help expand the system to handle growing Permian Basin volumes.
Abbott <
ABT.N
- said it would buy cancer-test maker Exact Sciences <
EXAS.O
- in a deal valued at up to $23 billion, including debt, marking one of its largest acquisitions in nearly a decade and its first major push into cancer screening.
Insurer Generali <
GAS.MI
, Milan-listed BFF Bank <
BFF.MI
- and France’s BPCE have advanced to the second round of bidding to acquire European life-insurance consolidator GamaLife from Apax Partners, two sources familiar with the matter said.
Palo Alto Networks (PANW.O) said it will buy cloud management and monitoring company Chronosphere for $3.35 billion, as the cybersecurity firm looks to strengthen its AI offerings.
